132 related articles for article (PubMed ID: 14065433)
1. POTENTIATION OF MONOAMINE-OXIDASE INHIBITORS BY TRYPTOPHAN.
PARE CM
Lancet; 1963 Sep; 2(7306):527-8. PubMed ID: 14065433
[No Abstract] [Full Text] [Related]
2. [ANTIDEPRESSIVE TREATMENT WITH MONOAMINE OXIDASE (MAO) INHIBITORS. I. SIDE-EFFECTS AND RISKS OF POTENTIATION].
HOLMBERG G; SJOEQVIST F
Sven Lakartidn; 1964 Dec; 61():3762-93. PubMed ID: 14276462
[No Abstract] [Full Text] [Related]
3. TOXIC EFFECTS OF MONOAMINE-OXIDASE INHIBITORS.
REES L; PARE CM
Lancet; 1963 Dec; 2(7320):1279-80. PubMed ID: 14066868
[No Abstract] [Full Text] [Related]
4. Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan.
COPPEN A; SHAW DM; FARRELL JP
Lancet; 1963 Jan; 1(7272):79-81. PubMed ID: 14022907
[No Abstract] [Full Text] [Related]
5. MONOAMINE-OXIDASE INHIBITORS.
GARMANY G
Lancet; 1964 Apr; 1(7339):932. PubMed ID: 14128077
[No Abstract] [Full Text] [Related]
6. Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor.
OATES JA; SJOERDSMA A
Neurology; 1960 Dec; 10():1076-8. PubMed ID: 13730138
[No Abstract] [Full Text] [Related]
7. The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine.
HESS SM; REDFIELD BG; UDENFRIEND S
J Pharmacol Exp Ther; 1959 Nov; 127():178-81. PubMed ID: 14401504
[No Abstract] [Full Text] [Related]
8. [Our experiences with monoamine oxidase inhibiting substances].
TAUBER CG
Psychiatr Neurol (Basel); 1960 Jul; 140():148-51. PubMed ID: 13775480
[No Abstract] [Full Text] [Related]
9. HYPERTENSIVE CRISIS ASSOCIATED WITH MONOAMINE-OXIDASE INHIBITORS.
BLACKWELL B; MARLEY E; RYLE A
Lancet; 1964 Mar; 1(7335):722-3. PubMed ID: 14107974
[No Abstract] [Full Text] [Related]
10. [On monoamine-oxidase inhibitors].
KROEBER E
Psychiatr Neurol (Basel); 1960 Jul; 140():92-6. PubMed ID: 13754442
[No Abstract] [Full Text] [Related]
11. A comparison of various amine oxidase inhibitors as antidepressants.
DUNLOP E
Psychosomatics; 1962; 3():53-6. PubMed ID: 13888486
[No Abstract] [Full Text] [Related]
12. THE CHOICE OF ANTIDEPRESSANTS IN VARIOUS TYPES OF DEPRESSION.
DUNLOP E
Psychosomatics; 1964; 5():107-10. PubMed ID: 14130880
[No Abstract] [Full Text] [Related]
13. A new and safer monoamine oxidase inhibitor.
ROBIE TR
J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():31-48. PubMed ID: 13742239
[No Abstract] [Full Text] [Related]
14. HAZARDS WITH MOMOAMINE-OXIDASE INHIBITORS.
TONKS CM; LLOYD AT
Br Med J; 1965 Feb; 1(5434):589. PubMed ID: 14243070
[No Abstract] [Full Text] [Related]
15. [EXPERIMENTAL AND CLINICAL CONSIDERATIONS ON A NEW ANTIDEPRESSIVE DRUG NOT AN ENCEPHALIC MONOAMINE OXIDASE INHIBITOR DERIVED FROM IPRONIAZIDE (TIBICOR)].
VANNI F
G Psichiatr Neuropatol; 1964; 92():1021-41. PubMed ID: 14304145
[No Abstract] [Full Text] [Related]
16. TREATMENT OF MILD ENDOGENOUS DEPRESSION WITH A MONO-AMINE OXIDASE INHIBITOR: A CONTROLLED TRIAL IN GENERAL PRACTICE.
MCWHINNEY IR; MORRELL DC
J Coll Gen Pract; 1965 Jan; 9(1):95-9. PubMed ID: 14254271
[No Abstract] [Full Text] [Related]
17. Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan.
Pope HG; Jonas JM; Hudson JI; Kafka MP
Am J Psychiatry; 1985 Apr; 142(4):491-2. PubMed ID: 3976924
[TBL] [Abstract][Full Text] [Related]
18. [PROSPECTIVES FOR THE USE OF MONOAMINE OXIDASE INHIBITORS IN PEDIATRICS].
ANSANELLI V
Pediatria (Napoli); 1964; 72():133-9. PubMed ID: 14163248
[No Abstract] [Full Text] [Related]
19. REACTIONS FOLLOWING THE INTRA-MUSCULAR ADMINISTRATION OF CHLORPROTHIXENE.
SIMPSON GM
Am J Psychiatry; 1964 Apr; 120():1021-3. PubMed ID: 14138840
[No Abstract] [Full Text] [Related]
20. TYRAMINE IN CHEESE RELATED TO HYPERTENSIVE CRISES AFTER MONOAMINE-OXIDASE INHIBITION.
BLACKWELL B; MABBITT LA
Lancet; 1965 May; 1(7392):938-40. PubMed ID: 14275713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
